Compare Davita Inc (DVA) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Sirius XM Holdings Inc — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while Sirius XM Holdings Inc trades at $28.55 (market cap $9.70B). The key difference: Davita Inc is the larger of the two by market cap, and Sirius XM Holdings Inc pays a 3.75% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | SIRI | |
|---|---|---|
Market Cap | $11.72B | $9.70B |
Sector | Health | Media |
52-Week High | $240.96 | $32.59 |
52-Week Low | $103.87 | $19.92 |
Enterprise Value | $24.44B | $18.98B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Sirius XM Holdings (SIRI) trades at $29.91, showing minimal daily movement (+0.1%) with a bullish technical signal from moving averages. The company demonstrates stable fundamentals with a P/E of 12.01 and net income margin of 10.23%, though Q2 2026 earnings missed expectations. Recent news highlights dividend declarations and institutional activity, while cash flow trends show improvement with projected positive net cash flow for 2026.
The outlook remains cautiously optimistic with analyst consensus favoring Buy ratings (58%) and a $33.17 price target suggesting 11% upside. Key risks include competitive pressures in audio streaming and execution challenges, but strong cash flow generation and reduced leverage support shareholder returns through dividends and potential buybacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
